Rule 1: A molecule may increase the chance of causing adverse effects on the heart if it contains functional groups like nitro groups and halogen groups.
Rule 2: In the absence of certain functional groups or structural features, a molecule may decrease its likelihood of causing heart-related adverse effects.
Rule 3: The molecular weight and hydrophobicity of a molecule could play a role in determining its potential for cardo toxicity.
Rule 4: The presence of chloride and carbonyl groups in a compound may heighten its potential to cause heart-related negative effects.
Rule 5: Compounds containing metal ions or rare earth elements could potentially increase the risk of heart-related adverse effects.
Rule 6: Certain structural features, such as a heterocyclic ring system, of a compound might contribute to increased chances of it causing adverse effects on the heart.
Rule 7: If a molecule contains a double bond between carbon atoms, it may increase its likelihood of causing heart-related adverse effects.
Rule 8: The presence of a nitrogen atom bonded to two carbon atoms in a molecule may increase its likelihood of causing heart-related adverse effects.
Rule 9: The presence of strontium ions in a molecule may decrease the likelihood of it causing heart-related adverse effects.
Rule 10: If a molecule contains a carbonyl group (C=O) in its structure, it could be indicative of the potential to cause adverse effects related to cardiac disorders.
Rule 11: If a molecule contains a sulfonyl group (SO2R), it may increase its likelihood of causing cardiac disorders.
Rule 12: The presence of a sulfonamide group in a compound could increase its risk of causing heart-related issues.
Rule 13: The presence of certain functional groups in a molecule potentially increases the chance of them causing adverse effects.
Rule 14: If a molecule contains a chlorine atom, it is likely to have heart-related side effects.
Rule 15: The presence of functional groups like carboxylic acid, ester, and amide in a compound could contribute to its potential for causing cardiac disorder side effects.
Rule 16: The presence of certain functional groups in a molecule may increase its likelihood of causing adverse effects on the heart. Examples of such groups include sulfonyl, carbonyl, and carboxylic acid groups.
Rule 17: The size and shape of a molecule could potentially impact its ability to interact with biological targets, potentially leading to adverse effects.
Rule 18: Certain substructures being present within a compound could indicate its potential to cause heart-related side-effects.
Rule 19: If a molecule contains a thiocyanate group (-SCN) or a sulfonamide group (-SO2NH2), it may have the potential to cause heart-related adverse effects.
Rule 20: If a functional group such as "-COOH" or "-OH" is present in the structure of a molecule, it may lead to adverse effects on the heart.
Rule 21: The presence of certain functional groups like sulfonyl, amides, carboxylic acid, and sulfonamides may increase the potential for a compound to cause adverse effects on the heart.
Rule 22: If a molecule contains a functional group like the thiocyanate group, it could potentially cause heart-related adverse effects.
Rule 1: Molecules that contain a functional group like "carbonyl" or in conjugation with another double bond or aromatic ring may potentially cause adverse cardiac disorders.
Rule 2: Presence of sulfonyl, carbonyl, and nitro groups or aromatic rings in a compound may elevate its chances of causing harmful effects on the heart.
Rule 3: The length and flexibility of a compound's carbon chain may have potential impacts on its ability to infiltrate cell membranes which may subsequently lead to increased toxicity or cardiotoxicity.
Rule 4: If a molecule contains a sulfonamide group (-SO2NH-), nitro group (-NO2), a cyano group (-CN) attached to an aromatic ring or a benzimidazole moiety, it may have potential cardiac-related adverse effects.
Rule 5: The existence of a sulfonamide group (-SO2NH-) or a similar functional group in a molecule, may elevate its potential to cause adverse effects related to cardiac disorders.
Rule 6: Molecules which have a sulfonyl group (-SO2R), or a sulfate group (-OSO3-), or a nitro group (-NO2) attached to an aromatic ring may be associated with higher risks of causing cardiovascular disorders or heart problems.
Rule 7: The presence of negatively charged ions like chloride and sulfate or the presence of multiple aromatic rings or conjugated double bonds in the molecular structure might potentially cause adverse effects on the heart.
Rule 8: If the functional group like "-NO2" or "-COOH" exists within a molecular structure, it may lead to adverse heart effects.
Rule 9: Presence of CN group in molecular structure attached to the benzene ring or any other aromatic system can lead to cardiotoxicity.
Rule 10: If a molecular structure contains a phosphorus atom bonded to four oxygen atoms in a cyclic structure or nitrogen-containing ring structure connected to a carbonyl group through a carbon-carbon bond or a thallium or chlorine atom, could potentially cause adverse effects related to cardiac disorders.
The context below seems to be missing. Could you please provide it so I can continue?
